A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
N-Methylhistamine, Random, Urine
Test Code39604
CPT Codes
82542, 82570
Preferred Specimen
5 mL random urine collected in a sterile, screw-cap container with no preservative
Patient Preparation
Patient must not be taking monoamine oxidase inhibitors (MAOIs) or aminoguanidine as these medications increase N-methylhistamine (NMH) levels.
Minimum Volume
3 mL
Instructions
1. Collect a random urine specimen within a few hours of symptom onset.
2. No preservative.
Advisory Information: Patients with chronic mast cell activation often have chronically elevated N-methylhistamine (NMH) levels and will sometimes have intermittent NMH elevations. In these cases, a 24-hour urine collection is preferred. See NMH24 /N-Methylhistamine, 24 Hour, Urine.
2. No preservative.
Advisory Information: Patients with chronic mast cell activation often have chronically elevated N-methylhistamine (NMH) levels and will sometimes have intermittent NMH elevations. In these cases, a 24-hour urine collection is preferred. See NMH24 /N-Methylhistamine, 24 Hour, Urine.
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 14 days
Refrigerated: 28 days
Frozen: 28 days
Refrigerated: 28 days
Frozen: 28 days
Methodology
NMHR1: Liquid Chromatography-Tandem Mass Spectrometry
CRETR: Enzymatic Colorimetric Assay
Setup Schedule
Set up: Tues, Thurs; Report available: 3 days
Reference Range
Age | (mcg/g Cr) |
0-5 years: | 120-510 |
6-16 years: | 70-330 |
> 16 years: | 30-200 |
Creatinine, Random, U | See Laboratory Report |
Clinical Significance
Screening for and monitoring of mastocytosis and disorders of systemic mast-cell activation, such as anaphylaxis and other forms of severe systemic allergic reactions using random urine specimens.
Monitoring therapeutic progress in conditions that are associated with secondary, localized, low-grade persistent, mast-cell proliferation and activation such as interstitial cystitis.
Monitoring therapeutic progress in conditions that are associated with secondary, localized, low-grade persistent, mast-cell proliferation and activation such as interstitial cystitis.
Performing Laboratory
Mayo Clinic Laboratories
200 First Street SW
Rochester, MN 55905